Keyphrases
Tumor
55%
In Cancer
45%
Neoantigen
44%
Variant Interpretation
35%
RNA Sequencing (RNA-seq)
31%
Clinical Interpretation
26%
Somatic mutation
25%
Somatic Variants
24%
Neoadjuvant
23%
Acute Myeloid Leukemia
20%
Whole Genome Sequencing
19%
Cancer Variants
19%
Interaction Database
19%
Drug-gene Interaction
19%
Follicular Lymphoma
19%
Neoantigen Prediction
16%
Clinical Genome Resource
15%
Triple-negative Breast Cancer
15%
Genomic Data
15%
Natural Killer Cells
14%
Curation
14%
Clonal Architecture
13%
Genomic Landscape
12%
Breast Cancer
12%
Community-based
12%
Crowdsourcing
12%
Phase II Trial
11%
Transcriptome
11%
Memory-like
11%
Cancer Genomics
11%
Whole Exome Sequencing
11%
ER+ Breast Cancer
11%
Pathological Complete Response
11%
Transcriptome Analysis
11%
Clinically Significant
10%
Complementary DNA (cDNA)
10%
Patient-derived Xenograft
10%
Melanoma
10%
Mutational Landscape
10%
Genome Analysis
9%
Sequence Data
9%
Head-and-neck Cancer
9%
Massively Parallel Sequencing
9%
Clinical Trials
9%
Pathogenicity
9%
Exon
9%
Microglia
9%
Standard Operating Procedures
9%
Cancer Patients
8%
Driver mutations
8%
Biochemistry, Genetics and Molecular Biology
Genomics
100%
RNA Sequencing
32%
Somatic Mutation
27%
Transcriptome
24%
RNA Sequence
24%
T Cell
21%
Deep Sequencing
20%
RNA
19%
Cancer Cell
19%
Gene Interaction
19%
Exome Sequencing
17%
Exome
17%
Isoform
16%
Germ Cell
16%
Germline
16%
Clinical Trial
15%
Genome Sequencing
15%
Genetics
15%
Cancer Genomics
15%
Whole Genome Sequencing
14%
Carcinogenesis
14%
Myeloid
14%
Molecular Cloning
13%
Allele
12%
Exon
12%
Bioinformatics
10%
Messenger RNA
10%
Medline
9%
B Cell
9%
Peptide Sequence
9%
KRAS
9%
Alternative Splicing
9%
Gene Fusion
9%
Gene Expression Profiling
8%
Kinase
8%
Phosphotransferase
8%
P53
8%
Epigenetics
8%
Mutated Genes
8%
Binding Site
7%
Gene Expression
7%
Transcription
7%
MicroRNA
7%
Fluorouracil
7%
Open Reading Frame
7%
Drug Resistance
7%
Transcription Factors
7%
Cancer Immunotherapy
7%
Point Mutation
6%
Binding Affinity
6%
Medicine and Dentistry
Neoplasm
58%
Malignant Neoplasm
58%
Somatics
24%
Breast Cancer
21%
Exome Sequencing
18%
Medicine
17%
Natural Killer Cell
15%
Follicular Lymphoma
15%
Somatic Mutation
15%
Acute Myeloid Leukemia
12%
Genome Sequencing
11%
Phase II Trials
11%
RNA Sequencing
11%
Carcinogenesis
9%
Clinical Trial
8%
Non-Hodgkin Lymphoma
8%
Clinical Stage
8%
Diseases
8%
Hematopoietic Cell
7%
T Cell
7%
Triple Negative Breast Cancer
7%
Head and Neck Cancer
7%
Pembrolizumab
7%
Diffuse Large B-Cell Lymphoma
7%
Anastrozole
7%
Treatment Response
6%
RNA Sequence
6%
Breast Cancer Cell Line
6%
Clinical Significance
6%
Tumor Progression
5%
Cell Transplantation
5%
Lenalidomide
5%
Rituximab
5%
Specific Tumor
5%
Pathogenicity
5%
Immunotherapy
5%